Eugene Zhukovsky joins Affimed as CSO
This article was originally published in Scrip
Affimed Therapeutics, a therapeutic antibody company, has appointed Dr Eugene Zhukovsky chief scientific officer, effective 1 January 2012. Dr Zhukovsky has 20 years' experience in biotherapeutics research and development. He was most recently a senior research fellow in the biotherapeutics department at Boehringer Ingelheim.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.